306 related articles for article (PubMed ID: 35946168)
21. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 Feb; 19(1):178. PubMed ID: 30813928
[TBL] [Abstract][Full Text] [Related]
22. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
[TBL] [Abstract][Full Text] [Related]
23. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
[No Abstract] [Full Text] [Related]
24. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
25. A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
Yeh CN; Wang SY; Chen YY; Chen MH; Chiang KC; Cheng CT; Tsai CY; Wang CC; Yeh TS; Chen TC
Anticancer Res; 2016 Aug; 36(8):4249-58. PubMed ID: 27466540
[TBL] [Abstract][Full Text] [Related]
26. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
27. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
Liu Z; Liu H; Wang D
Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
[TBL] [Abstract][Full Text] [Related]
28. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
29. Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?
Tong Y; Jiang L; Gong Y; Zhu D; Zhao D
Asian J Surg; 2024 Jan; 47(1):333-349. PubMed ID: 37741753
[TBL] [Abstract][Full Text] [Related]
30. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
31. Risk stratification system and visualized dynamic nomogram constructed for predicting diagnosis and prognosis in rare male breast cancer patients with bone metastases.
Gao B; Ou XL; Li MF; Wang MD; Huang F
Front Endocrinol (Lausanne); 2022; 13():1013338. PubMed ID: 36440188
[TBL] [Abstract][Full Text] [Related]
32. Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy.
Shi N; Zou Y; Zhang Y; Han H; Chen Z; Ruan S; Jin L; Ma Z; Chen Z; Lou Q; Jin H
J Oncol; 2020; 2020():8889571. PubMed ID: 33343665
[TBL] [Abstract][Full Text] [Related]
33. Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: A population-based analysis.
Tong Y; Pi Y; Cui Y; Jiang L; Gong Y; Zhao D
Front Oncol; 2022; 12():959804. PubMed ID: 36568161
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.
Zhu Y; Mao W; Zhang G; Sun S; Tao S; Jiang T; Wang Q; Meng Y; Wu J; Chen M
Front Public Health; 2022; 10():942608. PubMed ID: 36187680
[TBL] [Abstract][Full Text] [Related]
35. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
Front Public Health; 2022; 10():884349. PubMed ID: 35712294
[TBL] [Abstract][Full Text] [Related]
36. Individualized assessment of risk and overall survival in patients newly diagnosed with primary osseous spinal neoplasms with synchronous distant metastasis.
Tong Y; Huang Z; Jiang L; Pi Y; Gong Y; Zhao D
Front Public Health; 2022; 10():955427. PubMed ID: 36072380
[TBL] [Abstract][Full Text] [Related]
37. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors, Prognostic Factors, and Nomograms for Bone Metastasis in Patients with Newly Diagnosed Clear Cell Renal Cell Carcinoma: A Large Population-Based Study.
Zhou H; Yang S; Xie T; Wang L; Zhong S; Sheng T; Fan G; Liao X; Xu Y
Front Surg; 2022; 9():877653. PubMed ID: 35433803
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy.
Song J; Di Y; Kang X; Ren G; Wang Y
Front Public Health; 2023; 11():1012069. PubMed ID: 36817916
[TBL] [Abstract][Full Text] [Related]
40. Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
Hou GM; Jiang C; Du JP; Yuan KF
Cancer Med; 2022 Jan; 11(2):317-331. PubMed ID: 34866356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
